Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Oct;104(2):514–518. doi: 10.1111/j.1476-5381.1991.tb12460.x

Thermogenic and lipolytic effect of yohimbine in the dog.

J Galitzky 1, M Vermorel 1, M Lafontan 1, P Montastruc 1, M Berlan 1
PMCID: PMC1908559  PMID: 1797315

Abstract

1. Lipid mobilization during a hypocaloric diet may be enhanced by a pharmacological approach using alpha 2-adrenoceptor antagonists since these drugs are known to increase sympathetic tone and stimulate lipolysis. Studies were undertaken in the dog in order to evaluate the effects of oral yohimbine administration (alpha 2-adrenoceptor antagonist) on heat production, metabolic, endocrinological and cardiovascular parameters. 2. Acute oral yohimbine (0.25 or 0.40 mg kg-1) provoked an increase in plasma non-esterified fatty acids. The drug increased sympathetic nervous system activity as indicated by the increased level of plasma noradrenaline. These effects persisted during the entire experimental period (4 h). The increase in plasma noradrenaline level was two fold higher with the higher dose of yohimbine (0.4 mg kg-1). The plasma adrenaline level was increased only with the higher dose. 3. Yohimbine transiently increased plasma insulin and the effect was dose-dependent. 4. Yohimbine (0.25 mg kg-1) enhanced heart rate and arterial blood pressure. 5. The effect of yohimbine on oxygen consumption, carbon dioxide and heat production was determined by indirect calorimetry. The drug (0.25 mg kg-1) increased O2 consumption and CO2 and heat production 30 min after its administration and the effect persisted over the experimental period. The respiratory quotient, rather low in the fasting animals, remained unchanged. 6. The present work indicates that thermogenesis and lipid mobilization are enhanced during fasting in the dog by alpha 2-adrenoceptor blockade. Yohimbine also induced a transient increase in plasma insulin level and increased heart rate and blood pressure.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
514

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acheson K. J., Zahorska-Markiewicz B., Pittet P., Anantharaman K., Jéquier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr. 1980 May;33(5):989–997. doi: 10.1093/ajcn/33.5.989. [DOI] [PubMed] [Google Scholar]
  2. Astrup A., Bülow J., Madsen J., Christensen N. J. Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. Am J Physiol. 1985 May;248(5 Pt 1):E507–E515. doi: 10.1152/ajpendo.1985.248.5.E507. [DOI] [PubMed] [Google Scholar]
  3. Berlan M., Carpene C., Lafontan M., Dang-Tran L. Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization. Horm Metab Res. 1982 May;14(5):257–260. doi: 10.1055/s-2007-1018986. [DOI] [PubMed] [Google Scholar]
  4. Berlan M., Galitzky J., Riviere D., Foureau M., Tran M. A., Flores R., Louvet J. P., Houin G., Lafontan M. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women. Int J Obes. 1991 May;15(5):305–315. [PubMed] [Google Scholar]
  5. Cahill G. F., Jr, Herrera M. G., Morgan A. P., Soeldner J. S., Steinke J., Levy P. L., Reichard G. A., Jr, Kipnis D. M. Hormone-fuel interrelationships during fasting. J Clin Invest. 1966 Nov;45(11):1751–1769. doi: 10.1172/JCI105481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Connacher A. A., Jung R. T., Mitchell P. E. Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical beta adrenoceptor agonist. Br Med J (Clin Res Ed) 1988 Apr 30;296(6631):1217–1220. doi: 10.1136/bmj.296.6631.1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Bruijne J. J. Biochemical observations during total starvation in dogs. Int J Obes. 1979;3(3):239–247. [PubMed] [Google Scholar]
  8. Dulloo A. G., Miller D. S. Obesity: a disorder of the sympathetic nervous system. World Rev Nutr Diet. 1987;50:1–56. doi: 10.1159/000414168. [DOI] [PubMed] [Google Scholar]
  9. Galitzky J., Taouis M., Berlan M., Rivière D., Garrigues M., Lafontan M. Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Eur J Clin Invest. 1988 Dec;18(6):587–594. doi: 10.1111/j.1365-2362.1988.tb01272.x. [DOI] [PubMed] [Google Scholar]
  10. Henny C., Schutz Y., Buckert A., Meylan M., Jequier E., Felber J. P. Thermogenic effect of the new beta-adrenoreceptor agonist Ro 16-8714 in healthy male volunteers. Int J Obes. 1987;11(5):473–483. [PubMed] [Google Scholar]
  11. James W. P., Haraldsdottir J., Liddell F., Jung R. T., Shetty P. S. Autonomic responsiveness in obesity with and without hypertension. Int J Obes. 1981;5 Suppl 1:73–78. [PubMed] [Google Scholar]
  12. Jensen M. D., Haymond M. W., Gerich J. E., Cryer P. E., Miles J. M. Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest. 1987 Jan;79(1):207–213. doi: 10.1172/JCI112785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Joshua J. O. The obese dog and some clinical repercussions. J Small Anim Pract. 1970 Sep;11(9):601–606. doi: 10.1111/j.1748-5827.1970.tb05621.x. [DOI] [PubMed] [Google Scholar]
  14. Jung R. T., Shetty P. S., James W. P., Barrand M. A., Callingham B. A. Reduced thermogenesis in obesity. Nature. 1979 May 24;279(5711):322–323. doi: 10.1038/279322a0. [DOI] [PubMed] [Google Scholar]
  15. Klein S., Peters E. J., Holland O. B., Wolfe R. R. Effect of short- and long-term beta-adrenergic blockade on lipolysis during fasting in humans. Am J Physiol. 1989 Jul;257(1 Pt 1):E65–E73. doi: 10.1152/ajpendo.1989.257.1.E65. [DOI] [PubMed] [Google Scholar]
  16. Landsberg L., Young J. B. Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med. 1978 Jun 8;298(23):1295–1301. doi: 10.1056/NEJM197806082982306. [DOI] [PubMed] [Google Scholar]
  17. Lilavivathana U., Campbell R. G., Brodows R. G. Control of insulin secretion during fasting in man. Metabolism. 1978 Jul;27(7):815–821. doi: 10.1016/0026-0495(78)90216-0. [DOI] [PubMed] [Google Scholar]
  18. Ma S. W., Foster D. O. Starvation-induced changes in metabolic rate, blood flow, and regional energy expenditure in rats. Can J Physiol Pharmacol. 1986 Sep;64(9):1252–1258. doi: 10.1139/y86-211. [DOI] [PubMed] [Google Scholar]
  19. Milavec-Krizman M., Wagner H. Effects of the adrenergic agonists isoprenaline and noradrenaline and the alpha-blocking agents dihydroergotamine and phentolamine on the lipolysis in isolated fat cells of the rat, guinea pig, dog and man. Biochem Pharmacol. 1978;27(19):2305–2310. doi: 10.1016/0006-2952(78)90136-3. [DOI] [PubMed] [Google Scholar]
  20. Peterson H. R., Rothschild M., Weinberg C. R., Fell R. D., McLeish K. R., Pfeifer M. A. Body fat and the activity of the autonomic nervous system. N Engl J Med. 1988 Apr 28;318(17):1077–1083. doi: 10.1056/NEJM198804283181701. [DOI] [PubMed] [Google Scholar]
  21. Scheen A., Cession-Fossion A., Scheen-Lavigne M., Luyckx A. Diminution de la sécrétion d'adrénaline au cours de la diète hypocalorique protélique chez l'obèse. Ann Endocrinol (Paris) 1981 Dec;42(6):531–536. [PubMed] [Google Scholar]
  22. Scheidegger K., O'Connell M., Robbins D. C., Danforth E., Jr Effects of chronic beta-receptor stimulation on sympathetic nervous system activity, energy expenditure, and thyroid hormones. J Clin Endocrinol Metab. 1984 May;58(5):895–903. doi: 10.1210/jcem-58-5-895. [DOI] [PubMed] [Google Scholar]
  23. Taouis M., Berlan M., Montastruc P., Lafontan M. Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location. J Pharmacol Exp Ther. 1987 Sep;242(3):1041–1049. [PubMed] [Google Scholar]
  24. Taouis M., Berlan M., Montastruc P., Lafontan M. Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog. J Pharmacol Exp Ther. 1988 Dec;247(3):1172–1180. [PubMed] [Google Scholar]
  25. Valet P., Damase-Michel C., Taouis M., Montastruc J. L., Cotonat J., Montastruc P. Acute release of catecholamines on circulating blood cell adrenoceptors and metabolic indices in dog. Fundam Clin Pharmacol. 1988;2(4):267–276. doi: 10.1111/j.1472-8206.1988.tb00638.x. [DOI] [PubMed] [Google Scholar]
  26. Young J. B., Landsberg L. Suppression of sympathetic nervous system during fasting. Science. 1977 Jun 24;196(4297):1473–1475. doi: 10.1126/science.867049. [DOI] [PubMed] [Google Scholar]
  27. Zahorska-Markiewicz B., Kucio C., Piskorska D. Adrenergic control of lipolysis and metabolic responses in obesity. Horm Metab Res. 1986 Oct;18(10):693–697. doi: 10.1055/s-2007-1012409. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES